All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Antivirals for systemic use

Daklinza

(daclatasvir)

Uses, side effects, dosage information & price range

Bristol-Myers Squibb Pharma EEIG

About this medicine

Daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults (see sections 4.2, 4.4 and 5.1). For HCV genotype specific activity, see sections 4.4 and 5.1.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

XofluzaComposition: baloxavir marboxilRoche Registration GmbH
Price on RequestView Details →
GenvoyaComposition: elvitegravir;cobicistat;emtricitabine;tenofovir alafenamideGilead Sciences Ireland UC
Price on RequestView Details →
Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan)Composition: tenofovir disoproxilViatris Limited
Price on RequestView Details →
Ritonavir Viatris (previously Ritonavir Mylan)Composition: ritonavirViatris Limited
Price on RequestView Details →
Emtricitabine / Rilpivirine / Tenofovir Alafenamide ViatrisComposition: emtricitabine;rilpivirine;tenofovir alafenamideViatris Limited
Price on RequestView Details →

Key Information

Salt / Composition

daclatasvir

Category

Antivirals for systemic use

Manufacturer

Bristol-Myers Squibb Pharma EEIG

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.